Approval · Notice of Compliance 5153 · 1995

MS CONTIN: Notice of Compliance 5153

Issued March 9, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 5153
Date: March 9, 1995
Company: Purdue Frederick
Product type: Prescription Pharmaceutical
Submission: Supplement to a New Drug Submission (SNDS), supplement
Submission class: Other
Reason: New dosage form
Therapeutic class: Opioid analgesic

Products in this notice

Brand	DIN	Status today
MS CONTIN	02146827	Cancelled Post Market
MS CONTIN	02145944	Cancelled Post Market
MS CONTIN	02145952	Cancelled Post Market
MS CONTIN	02145960	Cancelled Post Market
MS CONTIN	02145979	—

Medicinal ingredients

MORPHINE SULFATE 30 MG per SUP
MORPHINE SULFATE 60 MG per SUP
MORPHINE SULFATE 100 MG per SUP
MORPHINE SULFATE 200 MG per SUP
MORPHINE SULFATE 300 MG per SUP